Pyxis Oncology (PYXS) Earnings Date & Reports

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PYXS is expected to report earnings to fall 75.05% to -32 cents per share on May 09

Pyxis Oncology PYXS Stock Earnings Reports

Q1'25

Est.

$-0.33

Q4'24

Missed

by $1.00

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.18

The last earnings report on March 19 showed earnings per share of -132 cents, missing the estimate of -31 cents. With 305.09K shares outstanding, the current market capitalization sits at 67.13M.

View a ticker or compare two or three

Compare

PYXS